Chemotherapy does not significantly affect elevated CCL2 levels in AML patients, but a higher post-chemotherapy CCL2 level than at diagnosis may indicate a high likelihood of relapse [74]. This evidence concerns the gene CCL2 and acute myeloid leukemia.